Glaukos Corp (GKOS)
130.98
+4.18
(+3.30%)
USD |
NYSE |
Oct 04, 16:00
130.95
-0.03
(-0.02%)
After-Hours: 20:00
Glaukos Shareholders Equity (Annual): 461.77M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 461.77M |
| December 31, 2022 | 530.00M |
| December 31, 2021 | 587.15M |
| December 31, 2020 | 667.45M |
| December 31, 2019 | 673.27M |
| December 31, 2018 | 173.86M |
| Date | Value |
|---|---|
| December 31, 2017 | 138.20M |
| December 31, 2016 | 117.27M |
| December 31, 2015 | 95.19M |
| December 31, 2014 | -151.30M |
| December 31, 2013 | -141.30M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
461.77M
Minimum
2023
673.27M
Maximum
2019
583.93M
Average
587.15M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Boston Scientific Corp | 19.28B |
| Intuitive Surgical Inc | 13.31B |
| Insulet Corp | 732.70M |
| Tandem Diabetes Care Inc | 313.63M |
| iRhythm Technologies Inc | 210.10M |